LIBERATE - LIposomal Bupivacaine vERsus Adjuncts in Total shouldErs
Status:
Recruiting
Trial end date:
2024-01-01
Target enrollment:
Participant gender:
Summary
This will be a single-center, prospective, randomized controlled cross-sectional study
comparing interscalene brachial plexus block with liposomal bupivacaine versus bupivacaine
with epinephrine and PF dexamethasone in patients undergoing primary shoulder arthroplasty.
Primary endpoint will be total opioid consumption in the first three post-operative days.